Stocktoria

NewtekOne, Inc. NEWT

Nasdaq · stock · National Commercial Banks · website · IPO 1980-03-17 · LEI

NewtekOne, Inc. (NEWT) earns a Piotroski F-score of 2/9 (weak financial health). It pays a dividend yielding 6.62% (safety: moderate).

Chart by TradingView
22/100
Stocktoria Quality Score · grade D
2/9
Piotroski F — financial health
Altman Z″ — distress risk
8.6%
Dividend yield 5y avg · moderate · Dividend payout 46.3%

Quality score trend · recomputed for each fiscal year

Piotroski F /9
1 3 2 2 2022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$12.81 as of 2026-08-12 · +11.9% 1y
$10.40$14.8352-wk
Market cap USD$424M
Dividend yield 5y avg8.6%
Return on equity 5y avg16.2%
Beta1.37
Employees572

Analyst price target

$16.80 +31.1% vs last
· 5 analysts
target range $13.00 – $25.00

Wall Street analyst consensus — a sentiment gauge, not our scoring.

How it ranks in Finance, Insurance & Real Estate · percentile among 1129 companies

Piotroski Fstronger than 14%
Return on equitystronger than 85%

Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 2/9 tests passed

Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
NEWTNewtekOne, Inc.2/97
MFGMIZUHO FINANCIAL GROUP INC4/9+7.6%
JPMJPMORGAN CHASE & CO2/915.5+2.8%
BACBANK OF AMERICA CORP /DE/5/913.5+6.8%
CCITIGROUP INC3/917+5.6%
COFCAPITAL ONE FINANCIAL CORP4/951.2+36.6%
USBUS BANCORP DE6/912.1+4.4%

All Finance, Insurance & Real Estate companies →

About NewtekOne, Inc.

NewtekOne, Inc. operates as the bank holding company for Newtek Bank, National Association that provides various business and financial solutions under the Newtek and NewtekOne brands to the small- and medium-sized business market. The company accepts demand, savings, NOW, money market, and time deposits; and provides loans including the United States small business administration loans, commercial and industrial loans, and commercial real estate loans. It is also involved in the provision of electronic payment processing services comprising credit and debit card processing services, check approval services, processing equipment, and software, as well as cloud-based point of sale systems for various restaurants, retail, assisted living, taxi cabs, parks, and golf course businesses. In addition, it offers wholesale brokerage insurance agency services; and payroll management, and related payment and tax reporting services to independent business owners, as well as inbound and outbound calling services. The company was formerly known as Newtek Business Services Corp. and changed its name to NewtekOne, Inc. in January 2023. NewtekOne, Inc. was founded in 1998 and is headquartered in Boca Raton, Florida.

FAQ

Is NEWT financially healthy?

NewtekOne, Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).

Does NEWT pay a dividend, and is it safe?

Yes. NewtekOne, Inc. pays a dividend yielding about 6.62% with a 46.3% payout ratio, rated “moderate” for safety.

How profitable is NEWT?

In FY2025, NewtekOne, Inc. had a return on equity of 15.2%.

Is NEWT overvalued or undervalued?

NewtekOne, Inc. trades at about 5.9× trailing earnings — below its 10-year norm (10-year range 6.2×–13.9×, median 6.8×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for NEWT?

The average Wall-Street price target for NewtekOne, Inc. is $16.80, about 31.1% above the recent price, from 5 analysts.

Is NEWT a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on NewtekOne, Inc.: a Piotroski F-score of 2/9, a P/E of about 7.0×, a dividend yield of 6.62%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.